Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Angular peri-orificial erythema (L53.900x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Granulosis rubra nasi is childhood nasal erythematous papules with hyperhidrosis; reassurance, topical steroids, avoid irritation, self-limited around puberty.
皮肤科Erythema is redness of skin from vascular dilation; identify/treat cause (infection/drug/physical/autoimmune), topical steroids, antihistamines, supportive care, biopsy if persistent.
皮肤科Erythematous condition (L53.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Scarlatiniform erythema is fine papular erythema from group-A strep (scarlet fever) or drug; treat strep (penicillin), antihistamines, stop drug, monitor for glomerulonephritis/rheumatic fever.
皮肤科Palmar erythema (L53.800x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Edematous erythema (L53.800x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other specified erythematous conditions (L53.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Other chronic figurate erythema (L53.300) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Marginal erythema (L53.200) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Rheumatic annular erythema (L53.101) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Erythema annulare centrifugum (L53.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Toxic erythema is generalized erythematous eruption from drugs/infection; stop culprit drug, antihistamines, topical steroids, supportive care, monitor SJS/TEN/DRESS.
皮肤科Erythema induratum (Bazin disease) is tuberculid nodular vasculitis on calves; antituberculous therapy, rest, treat TB, biopsy/culture, watch for ulceration.
皮肤科Erythema nodosum is tender erythematous subcutaneous nodules on shins; NSAIDs, rest/elevation, treat cause (streptococcal infection/sarcoidosis/IBD/drugs/sulfonamides), bed rest, potassium iodide.
皮肤科Severe erythema multiforme (L51.900x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Erythema multiforme (L51.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Erythema multiforme (exudativum) is target lesions from HSV/mycoplasma/drug; treat cause (antivirals/antibiotics/stop drug), supportive care, topical/systemic steroids, monitor SJS/TEN overlap.
皮肤科Erosive erythema multiforme (L51.800x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other erythema multiforme (L51.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|